203 related articles for article (PubMed ID: 35306242)
1. Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review.
Mirmosayyeb O; Ghaffary EM; Bagherieh S; Barzegar M; Dehghan MS; Shaygannejad V
Mult Scler Relat Disord; 2022 Apr; 60():103697. PubMed ID: 35306242
[TBL] [Abstract][Full Text] [Related]
2. New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review.
Harel T; Gorman EF; Wallin MT
Front Neurol; 2023; 14():1099758. PubMed ID: 37426444
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review.
Mirmosayyeb O; Ghaffary EM; Vaheb S; Pourkazemi R; Shaygannejad V
Rev Neurol (Paris); 2023 Apr; 179(4):265-281. PubMed ID: 36658048
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis.
Barzegar M; Mirmosayyeb O; Ebrahimi N; Bagherieh S; Afshari-Safavi A; Hosseinabadi AM; Shaygannejad V; Asgari N
Mult Scler Relat Disord; 2022 Jan; 57():103359. PubMed ID: 35158468
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report.
de Ruijter NS; Kramer G; Gons RAR; Hengstman GJD
Mult Scler Relat Disord; 2020 Nov; 46():102474. PubMed ID: 32892062
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Stastna D; Menkyova I; Drahota J; Mazouchova A; Adamkova J; Ampapa R; Grunermelova M; Peterka M; Recmanova E; Rockova P; Rous M; Stetkarova I; Valis M; Vachova M; Woznicova I; Horakova D
Mult Scler Relat Disord; 2021 Sep; 54():103104. PubMed ID: 34216998
[TBL] [Abstract][Full Text] [Related]
7. The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study.
Tomczak A; Han MH
Mult Scler Relat Disord; 2020 Oct; 45():102347. PubMed ID: 32645636
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Ma J; Yu H; Wang H; Zhang X; Feng K
J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021
[TBL] [Abstract][Full Text] [Related]
9. Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic.
Abboud H; Zheng C; Kar I; Chen CK; Sau C; Serra A
Mult Scler Relat Disord; 2020 Sep; 44():102249. PubMed ID: 32526698
[TBL] [Abstract][Full Text] [Related]
10. Vaccination in neuromyelitis optica spectrum disorders: Friend or enemy?
Cai H; Zhou R; Jiang F; Zeng Q; Yang H
Mult Scler Relat Disord; 2022 Feb; 58():103394. PubMed ID: 35216775
[TBL] [Abstract][Full Text] [Related]
11. Post-COVID Neuromyelitis Optica Spectrum Disorder.
Rafique S; Wasim A; Sultan T; Ahmad A
J Coll Physicians Surg Pak; 2021 Jul; 31(7):138-140. PubMed ID: 34271816
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders.
Apostolos-Pereira SL; Campos Ferreira L; Boaventura M; de Carvalho Sousa NA; Joca Martins G; d'Almeida JA; Pitombeira M; Silvestre Mendes L; Fukuda T; Souza Cabeça HL; Chaves Rocha L; Santos de Oliveira B; Vieira Stella CR; Lobato de Oliveira EM; de Souza Amorim L; Ferrari de Castro A; Pereira Gomes Neto A; Diogo Silva G; Bueno L; de Morais Machado M; Castello Dias-Carneiro R; Maciel Dias R; Porto Moreira A; Piccolo A; Kuntz Grzesiuk A; Muniz A; Diniz Disserol C; Ferreira Vasconcelos C; Kaimen-Maciel D; Sisterolli Diniz D; Comini-Frota E; Coronetti Rocha F; Cruz Dos Santos GA; Dadalti Fragoso Y; Sciascia do Olival G; Ruocco HH; Siqueira HH; Sato HK; Figueiredo JA; Cortoni Calia L; Teixeira Dourado ME; Scolari L; Ribeiro Soares Neto H; Melges L; Magno Gonçalves MV; Vellutini Pimentel ML; de Castro Ribeiro M; Gurrola Arambula O; Diniz da Gama P; Leite Menon R; Barbosa Thomaz R; de Rizo Morales R; Sobreira S; Machado SN; Gonsalves Jubé Ribeiro T; Coelho Santa Rita Pereira V; Maia Costa V; da Nóbrega Junior AW; Vieira Alves-Leon S; Mamprim de Morais Perin M; Donadi E; Adoni T; Gomes S; Brito Ferreira M; Callegaro D; Mendes MF; Brum D; von Glehn F;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34446434
[TBL] [Abstract][Full Text] [Related]
13. Causal relationships between susceptibility and severity of COVID-19 and neuromyelitis optica spectrum disorder (NMOSD) in European population: a bidirectional Mendelian randomized study.
Wang S; Wang L; Wang J; Zhu M
Front Immunol; 2023; 14():1305650. PubMed ID: 38111568
[TBL] [Abstract][Full Text] [Related]
14. Association between infections, the microbiome, vaccination, and neuromyelitis optica spectrum disorder.
Carnero Contentti E; Correale J
Mult Scler; 2023 Apr; 29(4-5):492-501. PubMed ID: 35903896
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review.
Shahmohammadi S; Doosti R; Shahmohammadi A; Mohammadianinejad SE; Sahraian MA; Azimi AR; Harirchian MH; Asgari N; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Jan; 27():350-363. PubMed ID: 30476871
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis.
Moghadasi AN; Mirmosayyeb O; Mohammadi A; Sahraian MA; Ghajarzadeh M
Mult Scler Relat Disord; 2021 Apr; 49():102757. PubMed ID: 33486400
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders.
Jovicevic V; Ivanovic J; Andabaka M; Tamas O; Veselinovic N; Momcilovic N; Mesaros S; Pekmezovic T; Drulovic J
Mult Scler Relat Disord; 2022 Jan; 57():103320. PubMed ID: 35158424
[TBL] [Abstract][Full Text] [Related]
18. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
[TBL] [Abstract][Full Text] [Related]
19. Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
Motahharynia A; Naghavi S; Shaygannejad V; Adibi I
Mult Scler Relat Disord; 2022 Oct; 66():104035. PubMed ID: 35858498
[TBL] [Abstract][Full Text] [Related]
20. A Clinical Approach to Existing and Emerging Therapeutics in Neuromyelitis Optica Spectrum Disorder.
Yong HYF; Burton JM
Curr Neurol Neurosci Rep; 2023 Sep; 23(9):489-506. PubMed ID: 37540387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
